Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | ERN1 | O75460 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8358481 | 0.85 | ALOX15 (0.54) | ALOX15ABCG2ALDH1A1KDM4EIDO1 | |
| SCHEMBL7189830 | 0.84 | ABCG2 (0.55) | ALOX15ABCG2ALDH1A1KDM4EIDO1 | |
| SCHEMBL1639535 | 0.82 | ALOX15 (0.55) | ALOX15ABCG2ALDH1A1KDM4EIDO1 | |
| SCHEMBL9243226 | 0.81 | KDM4E (0.50) | ALOX15ABCG2ALDH1A1KDM4EIDO1 | |
| SCHEMBL28517298 | 0.81 | ABCG2 (0.49) | ALOX15ABCG2ALDH1A1KDM4EIDO1 | |
| SCHEMBL13498479 | 0.81 | MEN1 (0.50) | ALOX15ABCG2ALDH1A1KDM4EIDO1 | |
| SCHEMBL29002134 | 0.81 | PLK1 (0.54) | PLK1ALDH1A1KDM4ENPC1RAB9A | |
| Ammonia Solution, Strong SCHEMBL9297223 | 0.79 | ALDH1A1 (0.59) | ABCG2ALDH1A1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL426582 | 0.79 | ABCG2 (0.54) | ABCG2ALDH1A1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL30714893 | 0.79 | ABCG2 (0.54) | ABCG2ALDH1A1KDM4EHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61075359-A | — | — | None | — | — | JP | disclosed |
| CN-106187882-A | Prepare method and the synthetic intermediate thereof of compound | 克洛维斯肿瘤学意大利公司 | 2016-12-07 | — | — | CN | disclosed |
| US-20100028952-A1 | FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES | WYETH (US) | 2010-02-04 | — | — | US | disclosed |
| US-20080274959-A1 | Actinomadura Chromoprotein, Apoprotein and Gene Cluster | WYETH (US) | 2008-11-06 | — | — | US | disclosed |
| JP-S6175359-A | PRODUCTION OF AZO PIGMENT AND ELECTROPHOTOGRAPHIC SENSITIVE BODY USING SAID AZO PIGMENT | CANON INC | 1986-04-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274959-A1 | Actinomadura Chromoprotein, Apoprotein and Gene Cluster | ACTR2, APOB, CACYBP | PLK1 4509/4885ALOX15 1760/4885ABCG2 2644/4885 |
| US-20100028952-A1 | FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES | DCXR, ACTR2, AMY2A | PLK1 4354/4885ALOX15 3120/4885ABCG2 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.